Franklin Biotechnology Discovery Fund's Q1 2025 report covers market trends, key holdings, risks, and outlook—essential ...

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapiesComplements and further expands ReciBioPharm’s AAV offeringAchieves industry-leading ...

Moderna and Benchling are focused on three priorities with this digital transformation: consolidating systems to create a seamless experience for scientists, automating scientific workflows, and ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to permanent cracks in the increasingly fragile research ecosystem, ...

The government now wants civil society organizations (CSOs) opposing the lifting of the ban on genetically modified organisms ...

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Previously disclosed data for troculeucel in Alzheimer's disease and solid tumors can be found on the Company's website at https://nkgenbiotech.com/scientific-publications/. News releases containing ...

Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...

South Korean government and biopharmaceutical industry representatives urged American policymakers May 7 to refrain from imposing tariffs on pharmaceutical imports, and to spare allies if pharma ...

In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...